ÐÒÔË·Éͧ¼Æ»®

Over two months in October–December 2024, PhD Candidate Ghazal Lessan Toussi in Carina Strell’s group at CCBIO was given the opportunity to be on a research lab stay in Dr. Watnick’s laboratory at Boston Children's Hospital in Boston, USA. This was organized in the CCBIO–VBP Lab Visit Program, which is part of the CCBIO INTPART collaboration. Ghazal returned with lots of new knowledge and... Read more

The Western Norway Regional Health Authorities (Helse Vest) has recently announced their project funding for 2025, and we are happy to see many Neuro-SysMed researchers in their announcement. In addition, other funding agencies have also granted support to our projects this fall.

The result of years of collaboration between CCBIO PI Jim Lorens and Rolf Brekken and other colleagues in the USA, Finland, Romania and Norway, is now published in Science Signaling, with research identifying nuclear AKT3 as a new biomarker of advanced malignancy and revealing the pathway that activates AKT3 to drive epithelial-to-mesenchymal transition in pancreatic cancer.

This year, one of CCBIO's students got the opportunity to have a 3-month research stay in Boston, due to CCBIO's INTPART collaboration with Harvard Medical School and Boston Children's Hospital. PhD Candidate Tessa Lohr reports of a great experience, highly recommending it to other young researchers.

CCBIO's Co-Director Line Bjørge receives support for her group's project "Rethinking Ovarian Cancer: Developing Diagnostic and Functional Tools and Designing Innovative Multimodal Treatment Strategies."

The Norwegian Cancer Society has recently allocated their 2024 grants to current cancer research projects. Eight researchers from Bergen made the final cut, including three from CCBIO.

HIPS research group has several ongoing projects, including collaborations with other research groups and national data registries. In this image you can see several of these projects.